Novel Biomarkers Catalyst Lab (NBCL)

NBCL is dedicated to the development and commercialization of novel biomarker-based assays that could become important diagnostic tools in clinical management. NBCL has extensive development experience across a broad array of immunoassay technology platforms, and our team is committed to rapidly delivering market-ready assays to our customers.

Please contact NBCL to discuss how our immunoassay development expertise might help you.